Walleye Capital’s 89bio ETNB Stock Holding History

Walleye Capital’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-24,426	Closed	-$359K	–	4715
2025 Q3	$359K	Buy	+24,426	New	+$249K	﹤0.01%	2865
2025 Q2	–	Sell	-44,592	Closed	-$369K	–	4640
2025 Q1	$324K	Sell	44,592 -388,254	-90%	-$3.39M	﹤0.01%	2896
2024 Q4	$3.38M	Sell	432,846 -2,452	-0.6%	-$20.2K	0.01%	1345
2024 Q3	$3.22M	Buy	435,298 +402,624	+1,232%	+$3.39M	0.01%	1517
2024 Q2	$262K	Buy	+32,674	New	+$292K	﹤0.01%	4092
2024 Q1	–	Sell	-30,193	Closed	-$337K	–	5534
2023 Q4	$337K	Sell	30,193 -55,056	-65%	-$506K	﹤0.01%	3282
2023 Q3	$1.32M	Buy	85,249 +35,366	+71%	+$594K	﹤0.01%	2052
2023 Q2	$945K	Buy	+49,883	New	+$876K	﹤0.01%	1895
2023 Q1	–	Sell	-479,756	Closed	-$6.11M	–	4047
2022 Q4	$6.11M	Buy	479,756 +45,635	+11%	+$411K	0.11%	229
2022 Q3	$2.51M	Buy	434,121 +139,171	+47%	+$611K	0.05%	443
2022 Q2	$950K	Buy	+294,950	New	+$890K	0.03%	673

Other funds holding ETNB

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Walleye Capital's ETNB Position: Q4 2025 in Review

Walleye Capital sold out of 89bio (ETNB) in Q4 2025, closing a stake of 24,426 shares — an estimated $359K sold.

Walleye Capital first reported a position in ETNB in Q2 2022 and held it in 11 quarters. The position peaked at $6.11M in Q4 2022. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

Walleye Capital reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
Walleye Capital sold 24,426 89bio shares in Q4 2025, an estimated $359K.
Walleye Capital first reported a position in 89bio in Q2 2022 and held it in 11 quarters.
Walleye Capital's 89bio position peaked at $6.11M in Q4 2022.
2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Walleye Capital's 13F filing for Q4 2025, filed 13 Feb 2026.